DUNCAN WERSINGER: Open Payments
NPI 1770924458 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 8 payments from 7 companies in 2025. Trend: 2023 $500 · 2024 $0 · 2025 $760
Food & beverage: $760
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $150 |
| UCB, Inc. | 1 | $140 |
| GENZYME CORPORATION | 1 | $121 |
| Galderma Laboratories, L.P. | 2 | $121 |
| Incyte Corporation | 1 | $113 |
| Medline Industries LP | 1 | $73 |
| Becton, Dickinson and Company | 1 | $42 |
Products named: TREMFYA, DUPIXENT, NEMLUVIO, OPZELURA, PowerGlide.
Industry payments across NY — which companies pay providers there.
